Clinical Trials Directory

Trials / Completed

CompletedNCT02818270

Evaluation of Aerosolized Drugs Deposition During Mechanical Ventilation

Evaluation of Aerosolized Drugs Deposition Delivered Through a Mechanical Ventilator

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Chang Gung University · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Aerosol delivery through a ventilator is influenced by numerous factors from ventilator-related, circuit-related to device-related factors. Aerosolized drug delivery through a ventilator system was studied on bench model with albuterol, yet the results were often overestimated. The objective of this study was to evaluate inhaled bronchodilator and mucolytic agents delivered through a ventilator system.

Detailed description

Aerosolized medication is used widely to patients with respiratory illness and admitted in the intensive care unit, and includes bronchodilators, steroids, mucolytics, and antibiotics. Aerosol delivery through a ventilator is influenced by numerous factors from ventilator-related, circuit-related to device-related factors. Aerosolized drug delivery through a ventilator system was studied on bench model with albuterol, yet the results were often overestimated. Only few clinical trials on aerosol delivery deposition were published in the last decades. In addition, inhaled bronchodilators, mucolytics, antibiotics, and steroids are often administered to ventilated patients in the intensive care units in Taiwan, but they are never studied. Therefore, the aim of this study was to evaluate inhaled bronchodilator and mucolytics (acetylcystine) delivered by a jet nebulizer through a ventilator system to intubated patients.

Conditions

Interventions

TypeNameDescription
DRUGSalbutamolSalbutamol (albuterol ) was delivered by a jet nebulizer with a 50 pis oxygen flow at 6 L/min.
DRUGAcetylcysteineAcetylcystine was delivered by a jet nebulizer with a 50 pis oxygen flow at 6 L/min.

Timeline

Start date
2016-06-01
Primary completion
2016-12-01
Completion
2016-12-31
First posted
2016-06-29
Last updated
2017-02-01

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT02818270. Inclusion in this directory is not an endorsement.